PRICE T ROWE ASSOCIATES INC /MD/ - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$515
-4.8%
57,843
+8.4%
0.00%
Q1 2024$541
-38.0%
53,379
-38.4%
0.00%
Q4 2023$872
-60.6%
86,604
-63.3%
0.00%
Q3 2023$2,212
-88.8%
235,927
-70.6%
0.00%
-100.0%
Q2 2023$19,674
+118.5%
802,034
+107.3%
0.00%
+200.0%
Q1 2023$9,005
-7.7%
386,945
+0.3%
0.00%
-50.0%
Q4 2022$9,761
-99.9%
385,648
+0.0%
0.00%
+100.0%
Q3 2022$7,436,000
+65.4%
385,609
+118.4%
0.00%0.0%
Q2 2022$4,496,000
-61.2%
176,539
-60.8%
0.00%0.0%
Q1 2022$11,583,000
-53.7%
450,363
-24.6%
0.00%
-50.0%
Q4 2021$25,015,000
+1474.3%
597,433
+1536.0%
0.00%
Q3 2021$1,589,000
-55.7%
36,519
-51.9%
0.00%
Q2 2021$3,586,000
+12.8%
75,853
+22.4%
0.00%
Q1 2021$3,178,000
+81.4%
61,979
-5.3%
0.00%
Q4 2020$1,752,000
+93.0%
65,416
+147.3%
0.00%
Q3 2020$908,00026,4560.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders